KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Interest Coverage Ratio (2019 - 2025)

Historic Interest Coverage Ratio for Esperion Therapeutics (ESPR) over the last 7 years, with Q3 2025 value amounting to 0.45.

  • Esperion Therapeutics' Interest Coverage Ratio rose 5749.68% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 23184.59%. This contributed to the annual value of 0.92 for FY2024, which is 13480.87% up from last year.
  • Per Esperion Therapeutics' latest filing, its Interest Coverage Ratio stood at 0.45 for Q3 2025, which was up 5749.68% from 0.35 recorded in Q2 2025.
  • In the past 5 years, Esperion Therapeutics' Interest Coverage Ratio registered a high of 5.15 during Q1 2024, and its lowest value of 10.19 during Q1 2021.
  • For the 5-year period, Esperion Therapeutics' Interest Coverage Ratio averaged around 2.2, with its median value being 2.81 (2023).
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first soared by 25253.5% in 2024, then crashed by 12206.67% in 2025.
  • Esperion Therapeutics' Interest Coverage Ratio (Quarter) stood at 4.14 in 2021, then increased by 28.37% to 2.97 in 2022, then grew by 5.16% to 2.81 in 2023, then soared by 90.43% to 0.27 in 2024, then plummeted by 67.8% to 0.45 in 2025.
  • Its Interest Coverage Ratio stands at 0.45 for Q3 2025, versus 0.35 for Q2 2025 and 1.14 for Q1 2025.